The Report “North America Biopreservation Media Market, By Product Type (Home-brew Media, Pre-formulated Media), By Application (Regenerative Medicines, Drug Discovery, Biobanking), By Country (U.S., Canada, Mexico) - Analysis and Forecasts to 2021” is estimated to grow to around $147.0 million by 2021, at a CAGR of 21.2% between 2016 and 2021.
Browse through the TOC of the North America Biopreservation Media Market for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on this report
Biopreservation is a vital method for the stabilization of natural and engineered tissues to permit transportation and extended shelf life. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation, and banking. These specimens can be cells, tissues and organs, macromolecules, fungi, viruses, and bacteria. Biopreservation maintains the integrity and functionality of cells outside the native environment for extended storage times.
The North America biopreservation media market was valued at $138.3 million in 2015, which is estimated to grow to around $366.5 million by 2021, at a CAGR of 17.6% between 2016 and 2021.
The biopreservation media market is driven by factors such as advancements in the regenerative market and biobanking. Corporate, government, and non-government organizations are making huge investments in cell-therapy and regenerative medicine research. These investments hold great promise to identify the cause of diseases, translate findings, and accelerate personalized medicine as well as to improve diagnostics, public health, and preventive measures. Investments in related research are also helping in expanding the market for biopreservation media.
The demand for biopreservation media is expected to be fuelled by human tissue biobanking, which is of particular importance for implementation of novel biomarkers into clinical trials. Regenerative medicine focuses on both regenerating damaged tissues and organs in the body as well as growing tissues and organs in the laboratory and then implanting them in the body. Biobanking is a technique similar to biorepository that stores the biological samples of human beings. The North America biopreservation media market is expected to receive impetus from rapid advancements in biobanking technology.
The key players in the biopreservation media market are Lifeline Scientific Inc. (U.S.), BioLife Solutions Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Wak-Chemie Medical GmbH (Germany), VWR International LLC (U.S.), and others.
This market is segmented and forecasted on the basis of type, application, and geography.
The types comprise home-brew and pre-formulated media where home-brew media is dominating the market while the applications consist of regenerative medicines, biobanking, and drug discovery. Based on application, it is segmented into regenerative medicine, drug discovery and biobanking. Report covers major countries which includes U.S., Canada and Mexico. The U.S. region accounted for the largest share in terms of revenue, followed by Canada.
This report also includes the market share and value chain analyses as well as market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Contact:
Mr. Priyank Tiwari
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013, India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com
